Healthcare
Pentixapharm’s Busy Week: FDA Fast-Track, Rights Offering, and a BaFin Review All in Play
Pentixapharm has packed a remarkable amount of activity into recent days. The radiopharmaceutical specialist is juggling a US regulatory milestone...
Just 40 Minutes a Week: New Research Lowers Bar for Dementia-Preventing Exercise
A fresh look at the latest World Health Organization guidelines, updated in 2026, suggests that up to 45 percent of...
Germany Orders Workers to Submit Medical Certificates from Day One After Absenteeism Costs Soar to €134 Billion
Germany’s federal government has approved a sweeping reform package that makes a doctor’s note mandatory from the very first day...
Partial Incapacity to Work Introduced in Germany From 2027: New Three-Tier System for Sick Leave
The German Bundestag passed a major healthcare reform on 10 July 2026 that will fundamentally change how long-term illness is...
Ocugen Prepares for Pivotal Conference Season with Promising Retinal Gene Therapy Data
A string of positive clinical readouts has given Ocugen a clear narrative to bring to ophthalmology’s biggest gatherings this month....
German Workplace Health Programs Drive 5‑Fold Jump in RV Fit Use as Wearable Tech Expands
A quiet revolution is underway in German occupational health. While fitness trackers have long been consumer gadgets, a growing number...
Hamburg Court Ruling Sharpens Rules for Disability Pension Access
A landmark decision by the Hamburg Social Court is reshaping how Germany handles claims for full disability pensions — especially...
Exoskeletons Show Promise in German Trades as Back Pain Prompts Rethink of Workplace Design
In a workshop in Esslingen earlier this month, workers in the skilled trades strapped on wearable robotic frames designed to...
Germany’s Labour and Health Overhaul: Day-One Sick Notes, High-Earner Dismissal Easing, and €18.8bn in Cuts
The German upper house, the Bundesrat, has approved the Beitragssatzstabilisierungsgesetz – a savings package designed to cut health-insurance spending by...
Novo Nordisk Deploys Tiered Pricing and Weekly Insulin to Broaden GLP-1 Reach as Medicare Uptake Lags
Medicare Part D prescriptions for Wegovy surged nearly 600 percent within six months of the FDA’s March 2024 cardiovascular risk...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
